Physician profile
Ellen A Puleo
NPI 1063560712
$1,718.52
in general payments reported to CMS, 2019-2025
11 companies · $437 in 2025
The $437 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $172 · 2021: $389 · 2022: $303 · 2023: $84.00 · 2024: $199 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $977.39 | 2019-2025 | Wegovy |
| Abbvie INC. | $219.91 | 2020-2025 | |
| Myovant Sciences INC. | $168.18 | 2021-2022 | |
| Lsi Solutions INC | $85.26 | 2021-2024 | Running Device, Ti-Knot |
| Daiichi Sankyo INC. | $82.91 | 2021-2024 | Injectafer |
| Sumitomo Pharma America, INC. | $62.06 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $32.20 | 2019-2024 | Endosee |
| Lilly USA, LLC | $31.94 | 2024-2025 | Zepbound, Jardiance |
| Therapeuticsmd, INC. | $24.66 | 2019-2022 | |
| Shield Therapeutics INC | $18.90 | 2025 | |
| Exeltis, USA INC. | $15.11 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Puleo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.